Revision of the diagnosis of T‐zone lymphoma in the father of a patient with autoimmune lymphoproliferative syndrome type II
暂无分享,去创建一个
[1] J. Puck,et al. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. , 1999, American journal of human genetics.
[2] P. Krammer,et al. The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations. , 1999, The Journal of clinical investigation.
[3] J. Puck,et al. The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis. , 1998, The Journal of pediatrics.
[4] E. Jaffe,et al. Pathological findings in human autoimmune lymphoproliferative syndrome. , 1998, The American journal of pathology.
[5] M. Schrappe,et al. Mutation analysis of CD95 (APO‐1/Fas) in childhood B‐lineage acute lymphoblastic leukaemia , 1998, British journal of haematology.
[6] U. Dianzani,et al. Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. , 1997, Blood.
[7] E. Jaffe,et al. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. , 1997, Blood.
[8] Warren Strober,et al. Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome , 1995, Cell.
[9] M. Engelhard,et al. Peripheral T‐cell non‐Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T‐zone lymphoma , 1994 .
[10] R. Ueda,et al. A phenotypic and genotypic study of three node‐based, low‐grade peripheral T‐cell lymphomas: Angioimmunoblastic lymphoma, T‐zone lymphoma, and lymphoepithelioid lymphoma , 1992, Cancer.
[11] C. Smith,et al. Chronic lymphadenopathy simulating malignant lymphoma. , 1966, The Journal of pediatrics.